KCG
NVO

Knight Capital Group’s Novo Nordisk NVO Stock Holding History

Knight Capital Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$1.13M Buy
+72,840
New +$1.21M 0.02% 907

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Knight Capital Group's NVO Position: Q2 2013 in Review

Knight Capital Group opened a new position in Novo Nordisk (NVO) in Q2 2013: 72,840 shares worth $1.13M. The stake represents 0.02% of the portfolio and ranks #907 among its holdings.

411 funds tracked by Wall St. Rank hold NVO as of Q2 2013.

  • Knight Capital Group held 72,840 shares of Novo Nordisk worth $1.13M as of Q2 2013.
  • Novo Nordisk was a new Knight Capital Group position in Q2 2013.
  • Novo Nordisk made up 0.02% of Knight Capital Group's portfolio in Q2 2013, its #907 holding.
  • 411 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.